Overview

Study Of CP-751,871 In Patients With Ewing's Sarcoma Family Of Tumors

Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
Define the efficacy of CP-751,871 in patients with Ewing's sarcoma family of tumors
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Pfizer
Treatments:
Antibodies, Monoclonal